Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$201.71 USD
+0.28 (0.14%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $201.97 +0.26 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Marsh & McLennan (MMC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$205.35 | $226.00 | $185.00 | 1.95% |
Price Target
Based on short-term price targets offered by 17 analysts, the average price target for Marsh & McLennan comes to $205.35. The forecasts range from a low of $185.00 to a high of $226.00. The average price target represents an increase of 1.95% from the last closing price of $201.43.
Analyst Price Targets (17)
Broker Rating
Marsh & McLennan currently has an average brokerage recommendation (ABR) of 2.89 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, two are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 11.11% and 5.56% of all recommendations. A month ago, Strong Buy made up 22.22%, while Buy represented 5.56%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 13 | 13 | 11 | 11 | 11 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.89 | 2.89 | 2.67 | 2.67 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/18/2024 | William Blair | Adam Klauber | Hold | Hold |
4/17/2024 | Piper Sandler | Paul Newsome | Strong Buy | Hold |
4/11/2024 | Evercore Partners | David Motemaden | Strong Buy | Strong Buy |
4/10/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Sell | Moderate Sell |
3/15/2024 | BMO Capital Markets | Michael Zaremski | Hold | Hold |
1/26/2024 | Raymond James | Charles G Peters | Moderate Buy | Moderate Buy |
1/25/2024 | Roth Capital Partners | Harry Fong | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.89 |
ABR (Last week) | 2.89 |
# of Recs in ABR | 18 |
Average Target Price | $205.35 |
LT Growth Rate | 6.90% |
Industry | Insurance - Brokerage |
Industry Rank by ABR | 34 of 252 |
Current Quarter EPS Est: | 2.59 |